TrialJAMA2021

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.

Siri Lillegraven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.